A randomized double-blind controlled study for the evaluation of the clinical efficacy of the Tibetan medicine 'Fifteen Weisaierdou Pills'
- Conditions
- silt-type gallstones
- Registration Number
- ITMCTR2000003470
- Lead Sponsor
- Qinghai Jiumei Tibetan Medicine Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Consensus Opinions on Medical Diagnosis and Treatment of Chronic Cholecystitis and Cholecystolithiasis in China (2018) Sand-type gallbladder Stone diagnostic criteria;
(2) It meets the diagnostic criteria of Tibetan medicine and is hot, with more than 5 clinical symptoms;
(3) The age range is 20-70 years old;
(4) Those who voluntarily participated in the research and signed the informed consent.
(1) Exclude patients with acute non-calculous cholecystitis, gallbladder polyps, gallbladder cancer, gastric ulcers, gastric erosion, etc. with severe stomach disease;
(2) Combined with other diseases, such as severe heart, brain, kidney, lung dysfunction and trauma;
(3) Pregnant women and lactating women.
(4) Have not taken other Chinese and Western medicines for treating cholecystitis within 15 days, such as Xiaoyanlidan tablets;
(5) Circumstances that other researchers think are not suitable for participating in the research.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method recurrence rate;Stone discharge time ;
- Secondary Outcome Measures
Name Time Method